Cargando…
Comparative genomics of non-pseudomonal bacterial species colonising paediatric cystic fibrosis patients
The genetic disorder cystic fibrosis is a life-limiting condition affecting ∼70,000 people worldwide. Targeted, early, treatment of the dominant infecting species, Pseudomonas aeruginosa, has improved patient outcomes; however, there is concern that other species are now stepping in to take its plac...
Autores principales: | Ormerod, Kate L., George, Narelle M., Fraser, James A., Wainwright, Claire, Hugenholtz, Philip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4579023/ https://www.ncbi.nlm.nih.gov/pubmed/26401445 http://dx.doi.org/10.7717/peerj.1223 |
Ejemplares similares
-
Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis
por: Deschamp, Ashley R, et al.
Publicado: (2017) -
Emergence of persistent Aspergillus terreus colonisation in a child with cystic fibrosis
por: Dunne, Katie, et al.
Publicado: (2015) -
Molecular characterisation of methicillin-resistant Staphylococcus aureus from chronically colonised cystic fibrosis paediatric patients in Brazil
por: Rodrigues, D. C. S., et al.
Publicado: (2020) -
The Anti-Pseudomonal Peptide D-BMAP18 Is Active in Cystic Fibrosis Sputum and Displays Anti-Inflammatory In Vitro Activity
por: Degasperi, Margherita, et al.
Publicado: (2020) -
Macrolides decrease the minimal inhibitory concentration of anti-pseudomonal agents against Pseudomonas aeruginosa from cystic fibrosis patients in biofilm
por: Lutz, Larissa, et al.
Publicado: (2012)